NEW DELHI: Roche India and Cipla said that the first batch of antibody cocktail (Casirivimab and Imdevimab) is now available in India, while a second batch will be made available by mid-June.
The antibody cocktail is for restricted use in emergency situation for the treatment of mild to moderate Covid, in patients who are at high risk of developing a severe disease, says a company statement.
FacebookTwitterLinkedinEMail
الهند تستعين بـ«دواء ترامب» لعلاج كورونا elwatannews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elwatannews.com Daily Mail and Mail on Sunday newspapers.
Roche s COVID-19 antibody cocktail launched in India : Bulletin: Business Today businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.